Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A13419 | Pages: 203 | Charts: 59 | Tables: 99 |
The global microalgae market was valued at $977.3 million in 2020, and is projected to reach $1,485.1 million by 2028, registering a CAGR of 5.4%. North America was the highest revenue contributor in 2020, and is estimated to be dominant throughout the forecast period. Asia-Pacific is estimated grow at a significant CAGR of 6.7%. North America and Europe collectively accounted for a hefty contribution in the global microalgae market share in 2020.
Microalgae is a microscopic algae which is usually found in marine water and fresh water. The microalgae is a rich source of minerals and nutrition such as vitamin A, B1, B2, C, E, protein, iron and magnesium. Due to these properties the microalgae is used commercially in various industries such as dietary supplement, food/feed, pharmaceutal, cosmetic and biofuels. The application of microalgae products in these industry leads to the surge in the awareness of microalgae products among the customers.
Get more information on this report : Request Sample Pages
The microalgae market is subject to stable growth in the coming years. The growth of the market can be attributed to growing application of algal protein in dietary supplements and food industry. Moreover, algal protein is not considered an animal protein source, hence is perfect for consumption among the vegan population. Furthermore, microalgae has multiple applications which includes cosmetics, and feed industry.
Both feed and cosmetic industry has experience a surge in growth in the recent decade which has increased the demand of such products on a global level and as a resulted in an increase in the demand for microalgae. Thus, the abovementioned factors act as the key driving forces of the Microalgae market. However, the uncertainties in climatic conditions leading to problems in algae production act as the restraint, hindering the market growth. On the contrary, breakthroughs in microalgae production technology and growing adoption of microalgae in fortified food sector is expected to provide opportunities for growth for the microalgae market in the coming years.
The outbreak of the COVID-19 pandemic has marginally affected the microalgae market. People are restricted to stay at their homes to stop the further spread of the diseases. Governments have been forced to introduce and maintain social and mobility restrictions in an attempt to control spread of the disease. In this context, the microalgae production went on a temporarily halt and the production units were shut for a temporarily period of time. Furthermore, due to the lockdown, the disruption in supply chain also affected the microalgae business. However, the demand for microalgae during the lockdown has increased. This can be attributed to the fact that consumers all around the world have started investing in dietary supplements and fortified food to stay healthy.
The Microalgae market has been segmented based on the type, application and region. Based on type, the Microalgae market is divided into spirulina, chlorella, dunaliella salina, and aphanizomenon flos-aquae. In addition, the report segments the market on the basis of application which includes dietary supplements, food/feed, pharmaceutical, cosmetic, bio fuel and others. Furthermore, it includes the revenue generated from the sales of Microalgae across North America (U.S., Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, and rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea and rest of Asia-Pacific), and LAMEA (Latin America, Middle East and Africa).
Based on microalgae market analysis by type, the market is segmented into spirulina, chlorella, dunaliella salina, and aphanizomenon flos-aquae. In which the spirulina is the largest contributor to the market growth. The growth attributes to the fact that it is efficient for the production of dietary supplements, due to properties such as phycocyanins, anti-oxidant, phenolics and anti-inflammation. These properties makes spirulina an ideal ingredient in the production of dietary supplements and edibles.
[TYPEGRAPH]
Get more information on this report : Request Sample Pages
Based on microalgae market forecast by application, market is fragmented into dietary supplements, food/feed, pharmaceutal, cosmetic, and others. Among these application the dietary supplements share the largest market share. This is because the microalgae is rich in nutrition such as protein, vitamin and minerals. The presence of these nutrition makes microalgae ideal for the production pills, powders and capsules. Furthermore, the microalgae products are gaining traction in healthcare and nutrition industries due to these factors.
[APPLICATIONGRAPH]
Get more information on this report : Request Sample Pages
Region wise, North America dominated the microalgae market size in 2020, and is expected to sustain its dominance throughout the forecast period. The key factors driving microalgae market growth in the region include rise in awareness of nutritional values of microalgae in cosmetic, dietary supplements and food/feed industries. Also, the rise in disposable income and health and wellness contributes to the market growth.
[REGIONGRAPH]
Get more information on this report : Request Sample Pages
The players operating in the global microalgae market have adopted various developmental strategies to expand their market share, increase profitability, and remain competitive in the market. The key players profiled in this report include include Algenol Biotech, Cellana Inc., Cyanotech Corporation, DIC Corporation, E.I.D Parry ltd, Fuqing King Dnarmsa Spirulina Co. Ltd., Kent BioEnergy Corporation, Taau Australia Pty Ltd., Holdings, Inc. and Astareal AB.
By Type
By Application
By Region
Key Market Segments
Key Market Players
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.5.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Microalgae market snapshot
2.2.Key findings of the study
2.3.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Multiple benefits of micro-algal protein to amplify market growth
3.4.1.2.Increase in vegan population to strengthen product adoption
3.4.1.3.High protein concentration as compared to counter parts
3.4.2.Restraints
3.4.2.1.Impact on spirulina production due to climate change
3.4.2.2.Presence of large number of alternatives for protein, along with low product awareness
3.4.3.Opportunities
3.4.3.1.Novel innovations in technology to provide lucrative opportunities for market expansion
3.4.3.2.Algae protein fortified food to gain significant traction in upcoming years
3.5.COVID-19 impact analysis
3.5.1.Introduction
3.5.2.Impact on Microalgae market
3.6.Value Chain Analysis
3.7.Top Impacting factors
CHAPTER 4:MICROALGAE MARKET, BY TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Spirulina
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market size and forecast, by country
4.3.Chlorella
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market size and forecast, by country
4.4.Dunaliella Salina
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market size and forecast, by country
4.5.Aphanizomenon Flos-Aquae
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market size and forecast, by country
CHAPTER 5:MICROALGAE MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
Dietary Supplements
5.1.2.Key market trends, growth factors, and opportunities
5.1.3.Market size and forecast, by region
5.1.4.Market size and forecast, by country
5.2.Food/Feed
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market size and forecast, by country
5.3.Pharmaceutical
5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market size and forecast, by country
5.4.Cosmetic
5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market size and forecast, by country
5.5.Others
5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast, by region
5.5.3.Market size and forecast, by country
CHAPTER 6:MICROALGAE MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast, by region
6.2.North America
6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by type
6.2.3.Market size and forecast, by application
6.2.4.Market size and forecast, by country
6.2.5.U.S.
6.2.5.1.Market size and forecast, by type
6.2.5.2.Market size and forecast, by application
6.2.6.Canada
6.2.6.1.Market size and forecast, by type
6.2.6.2.Market size and forecast, by application
6.2.7.Mexico
6.2.7.1.Market size and forecast, by type
6.2.7.2.Market size and forecast, by application
6.3.Europe
6.3.1.Key market trends, growth factors, and opportunities
6.3.3.Market size and forecast, by type
6.3.4.Market size and forecast, by application
6.3.5.Market size and forecast, by country
6.3.6.Germany
6.3.6.1.Market size and forecast, by type
6.3.6.2.Market size and forecast, by application
6.3.7.UK
6.3.7.1.Market size and forecast, by type
6.3.7.2.Market size and forecast, by application
6.3.8.France
6.3.8.1.Market size and forecast, by type
6.3.8.2.Market size and forecast, by application
6.3.9.Italy
6.3.9.1.Market size and forecast, by type
6.3.9.2.Market size and forecast, by application
6.3.10.Spain
6.3.10.1.Market size and forecast, by type
6.3.10.2.Market size and forecast, by application
6.3.11.Rest of Europe
6.3.11.1.Market size and forecast, by type
6.3.11.2.Market size and forecast, by application
6.4.Asia-Pacific
6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by type
6.4.3.Market size and forecast, by application
6.4.4.Market size and forecast, by country
6.4.5.China
6.4.5.1.Market size and forecast, by type
6.4.5.2.Market size and forecast, by application
6.4.6.India
6.4.6.1.Market size and forecast, by type
6.4.6.2.Market size and forecast, by application
6.4.7.Japan
6.4.7.1.Market size and forecast, by type
6.4.7.2.Market size and forecast, by application
6.4.8.South Korea
6.4.8.1.Market size and forecast, by type
6.4.8.2.Market size and forecast, by application
6.4.9.Australia
6.4.9.1.Market size and forecast, by type
6.4.9.2.Market size and forecast, by application
6.4.10.Rest of Asia-Pacific
6.4.10.1.Market size and forecast, by type
6.4.10.2.Market size and forecast, by application
6.5.LAMEA
6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast, by type
6.5.3.Market size and forecast, by application
6.5.5.Market size and forecast, by country
6.5.6.Latin America
6.5.6.1.Market size and forecast, by type
6.5.6.2.Market size and forecast, by application
6.5.7.Middle East
6.5.7.1.Market size and forecast, by type
6.5.7.2.Market size and forecast, by application
6.5.8.Africa
6.5.8.1.Market size and forecast, by type
6.5.8.2.Market size and forecast, by application
CHAPTER 7:COMPETITION LANDSCAPE
7.1.Top winning strategies
7.2.Competitive dashboard
7.3.Competitive heat map
7.4.Key developments
7.4.1.Business Expansion
7.4.2.Partnership
7.4.3.Agreement
7.4.4.Product Launch
CHAPTER 8:COMPANY PROFILES
8.1.Introduction
8.2.ALGENOL BIOTECH
8.2.1.Company overview
8.2.2.Key Executive
8.2.3.Company snapshot
8.2.4.Product portfolio
8.3.CELLANA, INC.
8.3.1.Company overview
8.3.2.Key Executives
8.3.3.Company snapshot
8.3.4.Product portfolio
8.3.5.Key strategic moves and developments
8.4.CYANOTECH CORPORATION
8.4.1.Company overview
8.4.2.Key Executives
8.4.3.Company snapshot
8.4.4.Operating business segments
8.4.5.Product portfolio
8.4.6.R&D Expenditure
8.4.7.Business performance
8.4.8.Key strategic moves and developments
8.5.DIC CORPORATION
8.5.1.Company overview
8.5.2.Key Executives
8.5.3.Company snapshot
8.5.4.Operating business segments
8.5.5.Product portfolio
8.5.6.R&D Expenditure
8.5.7.Business performance
8.6.FUQING KING DNARMSA SPIRULINA CO., LTD.
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Product portfolio
8.7.TERRAVIA HOLDINGS, INC.
8.7.1.Company overview
8.7.2.Key Executives
8.7.3.Company snapshot
8.7.4.Operating business segments
8.7.5.Product portfolio
8.7.6.Business performance
8.8.ASTAREAL AB
8.8.1.Company overview
8.8.2.Key Executives
8.8.3.Company snapshot
8.8.4.Product portfolio
8.9.NECTON SA
8.9.1.Company overview
8.9.2.Key Executives
8.9.3.Company snapshot
8.9.4.Product portfolio
8.10.ROYAL DSM OCEAN NUTRITION
8.10.1.Company overview
8.10.2.Key Executives
8.10.3.Company snapshot
8.10.4.Operating business segments
8.10.5.Product portfolio
8.10.6.Business performance
8.11.BIOPROCESS ALGAE LLC
8.11.1.Company overview
8.11.2.Key Executives
8.11.3.Company snapshot
8.11.4.Product portfolio
LIST OF TABLES
TABLE 01.MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 02.SPIRULINA MICROALGAE MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 03.CHLORELLA MICROALGAE MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 04.DUNALIELLA SALINA MICROALGAE MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 05.APHANIZOMENON FLOS-AQUAE MICROALGAE MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 06.MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 07.MICROALGAE MARKET FOR DIETARY SUPPLEMENTS, BY REGION, 2020–2028 ($MILLION)
TABLE 08.MICROALGAE MARKET FOR FOOD/FEED, BY REGION, 2020–2028 ($MILLION)
TABLE 09.MICROALGAE MARKET FOR PHARMACEUTICAL, BY REGION, 2020–2028 ($MILLION)
TABLE 10.MICROALGAE MARKET FOR COSMETIC, BY REGION, 2020–2028 ($MILLION)
TABLE 11.MICROALGAE MARKET FOR OTHERS, BY REGION, 2020–2028 ($MILLION)
TABLE 12.MICROALGAE MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 13.NORTH AMERICA MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 14.NORTH AMERICA MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 15.NORTH AMERICA MICROALGAE MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 16.U.S. MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 17.U.S. MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 18.CANADA MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 19.CANADA MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 20.MEXICO MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 21.MEXICO MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 22.EUROPE MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 23.EUROPE MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 24.EUROPE MICROALGAE MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 25.GERMANY MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 26.GERMANY MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 27.UK MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 28.UK MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 29.FRANCE MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 30.FRANCE MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 31.ITALY MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 32.ITALY MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 33.SPAIN MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 34.SPAIN MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 35.REST OF EUROPE MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 36.REST OF EUROPE MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 37.ASIA-PACIFIC MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 38.ASIA-PACIFIC MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 39.ASIA-PACIFIC MICROALGAE MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 40.CHINA MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 41.CHINA MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 42.INDIA MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 43.INDIA MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 44.JAPAN MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 45.JAPAN MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 46.SOUTH KOREA MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 47.SOUTH KOREA MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 48.AUSTRALIA MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 49.AUSTRALIA MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 50.REST OF ASIA-PACIFIC MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 51.REST OF ASIA-PACIFIC MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 52.LAMEA MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 53.LAMEA MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 54.LAMEA MICROALGAE MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 55.LATIN AMERICA MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 56.LATIN AMERICA MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 57.MIDDLE EAST MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 58.MIDDLE EAST MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 59.AFRICA MICROALGAE MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 60.AFRICA MICROALGAE MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 61.ALGENOL BIOTECH: KEY EXECUTIVE
TABLE 62.ALGENOL BIOTECH: COMPANY SNAPSHOT
TABLE 63.ALGENOL BIOTECH: PRODUCT PORTFOLIO
TABLE 64.CELLANA, INC.: KEY EXECUTIVES
TABLE 65.CELLANA, INC.: COMPANY SNAPSHOT
TABLE 66.CELLANA, INC.: PRODUCT PORTFOLIO
TABLE 67.CYANOTECH CORPORATION : KEY EXECUTIVES
TABLE 68.CYANOTECH CORPORATION : COMPANY SNAPSHOT
TABLE 69.CYANOTECH CORPORATION : OPERATING SEGMENTS
TABLE 70.CYANOTECH CORPORATION : PRODUCT PORTFOLIO
TABLE 71.CYANOTECH CORPORATION : R&D EXPENDITURE, 2018–2020 ($MILLION)
TABLE 72.CYANOTECH CORPORATION : NET SALES, 2018–2020 ($MILLION)
TABLE 73.DIC CORPORATION: KEY EXECUTIVES
TABLE 74.DIC CORPORATION: COMPANY SNAPSHOT
TABLE 75.DIC CORPORATION: OPERATING SEGMENTS
TABLE 76.DIC CORPORATION: PRODUCT PORTFOLIO
TABLE 77.DIC CORPORATION: R&D EXPENDITURE, 2018–2020 ($MILLION)
TABLE 78.DIC CORPORATION: NET SALES, 2018–2020 ($MILLION)
TABLE 79.FUQING KING DNARMSA SPIRULINA CO., LTD. : COMPANY SNAPSHOT
TABLE 80.FUQING KING DNARMSA SPIRULINA CO., LTD. : PRODUCT PORTFOLIO
TABLE 81.TERRAVIA HOLDINGS, INC.: KEY EXECUTIVES
TABLE 82.TERRAVIA HOLDINGS, INC.: COMPANY SNAPSHOT
TABLE 83.TERRAVIA HOLDINGS, INC.: OPERATING SEGMENTS
TABLE 84.TERRAVIA HOLDINGS, INC.: PRODUCT PORTFOLIO
TABLE 85.TERRAVIA HOLDINGS, INC.: NET SALES, 2018–2020 ($MILLION)
TABLE 86.ASTAREAL AB: KEY EXECUTIVES
TABLE 87.ASTAREAL AB: COMPANY SNAPSHOT
TABLE 88.ASTAREAL AB: PRODUCT PORTFOLIO
TABLE 89.NECTON SA: KEY EXECUTIVES
TABLE 90.NECTON SA: COMPANY SNAPSHOT
TABLE 91.NECTON SA: PRODUCT PORTFOLIO
TABLE 92.ROYAL DSM : KEY EXECUTIVES
TABLE 93.ROYAL DSM : COMPANY SNAPSHOT
TABLE 94.ROYAL DSM : OPERATING SEGMENTS
TABLE 95.ROYAL DSM : PRODUCT PORTFOLIO
TABLE 96.ROYAL DSM : NET SALES, 2018–2020 ($MILLION)
TABLE 97.BIOPROCESS ALGAE LLC: KEY EXECUTIVES
TABLE 98.BIOPROCESS ALGAE LLC: COMPANY SNAPSHOT
TABLE 99.BIOPROCESS ALGAE LLC: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.MICROALGAE MARKET SEGMENTATION
FIGURE 02.MICROALGAE MARKET, 2020–2028
FIGURE 03.TOP INVESTMENT POCKET, BY COUNTRY
FIGURE 04.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 05.MODERATE BARGAINING POWER OF BUYERS
FIGURE 06.HIGH THREAT OF NEW ENTRANTS
FIGURE 07.MODERATE THREAT OF SUBSTITUTES
FIGURE 08.MODERATE INTENSITY OF COMPETITIVE RIVALRY
FIGURE 09.MICROALGAE MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 10.VALUE CHAIN ANALYSIS: MICROALGAE MARKET
FIGURE 11.TOP IMPACTING FACTORS: MICROALGAE MARKET
FIGURE 12.MICROALGAE MARKET, BY TYPE, 2020 (%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF SPIRULINA MICROALGAE MARKET, BY COUNTRY, 2020–2028 (%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF CHLORELLA MICROALGAE MARKET, BY COUNTRY, 2020–2028 (%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF DUNALIELLA SALINA MICROALGAE MARKET, BY COUNTRY, 2020–2028 (%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF APHANIZOMENON FLOS-AQUAE MICROALGAE MARKET, BY COUNTRY, 2020–2028 (%)
FIGURE 17.MICROALGAE MARKET, BY SOURCE, 2020 (%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF MICROALGAE MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2020–2028 (%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF MICROALGAE MARKET FOR FOOD/FEED, BY COUNTRY, 2020–2028 (%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF MICROALGAE MARKET FOR PHARMACEUTICAL, BY COUNTRY, 2020–2028 (%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF COSMETICS MICROALGAE MARKET, BY COUNTRY, 2020–2028 (%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF MICROALGAE MARKET FOR OTHERS, BY COUNTRY, 2020–2028 (%)
FIGURE 23.MICROALGAE MARKET, BY REGION, 2020 (%)
FIGURE 24.U.S. MICROALGAE MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 25.CANADA MICROALGAE MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 26.MEXICO MICROALGAE MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 27.GERMANY MICROALGAE MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 28.UK MICROALGAE MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 29.FRANCE MICROALGAE MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 30.ITALY MICROALGAE MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 31.SPAIN MICROALGAE MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 32.REST OF EUROPE MICROALGAE MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 33.CHINA MICROALGAE MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 34.INDIA MICROALGAE MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 35.JAPAN MICROALGAE MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 36.SOUTH KOREA MICROALGAE MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 37.AUSTRALIA MICROALGAE MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 38.REST OF ASIA-PACIFIC MICROALGAE MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 39.LATIN AMERICA MICROALGAE MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 40.MIDDLE EAST MICROALGAE MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 41.AFRICA MICROALGAE MARKET REVENUE, 2020–2028 ($MILLION)
FIGURE 42.TOP WINNING STRATEGIES, BY YEAR, 2018–2021*
FIGURE 43.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021* (%)
FIGURE 44.TOP WINNING STRATEGIES, BY COMPANY, 2018–2021*
FIGURE 45.COMPETITIVE DASHBOARD OF TOP 10 KEY PLAYERS
FIGURE 46.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 47.CYANOTECH CORPORATION : R&D EXPENDITURE, 2018–2020 ($MILLION)
FIGURE 48.CYANOTECH CORPORATION : NET SALES, 2018–2020 ($MILLION)
FIGURE 49.CYANOTECH CORPORATION: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 50.CYANOTECH CORPORATION: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 51.DIC CORPORATION: R&D EXPENDITURE, 2018–2020 ($MILLION)
FIGURE 52.DIC CORPORATION: NET SALES, 2018–2020 ($MILLION)
FIGURE 53.DIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 54.DIC CORPORATION: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 55.TERRAVIA HOLDINGS, INC.: NET SALES, 2018–2020 ($MILLION)
FIGURE 56.TERRAVIA HOLDINGS, INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 57.TERRAVIA HOLDINGS, INC.: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 58.ROYAL DSM : NET SALES, 2018–2020 ($MILLION)
FIGURE 59.ROYAL DSM: REVENUE SHARE, BY SEGMENT, 2020 (%)